Top 3 Trends Set to Gain More Strength in 2023
I'm sure many of us are looking forward to wrapping up this tumultuous year for the markets sooner rather than later.
In fact, with only a few days left in 2022, I thought it would be the perfect time to review the top three trends that took off this year and will continue to gain more traction in the New Year.
So, here are a few recent Pivotal Point articles I wrote that highlight these three growing trends, plus one bonus idea I couldn't possibly leave off this list. Hopefully these will prepare us for a new year of profit-taking in 2023.
Netflix Announces Projected Ad-Supported Subscription Revenue
Television is about to change, and investors should get ready. Executives of the streaming giant announced that its new ad-supported tier would make about the same revenue per user as current subscription plans. Bottom line — digital ads should ignite growth. That's why long-term investors should consider purchasing shares of this stock into weakness.
Inflation fears in 2022 have dominated the news cycle. But it is now clear thatone American fast-food company has a fix. McDonald's (MCD) posted strong Q3 financial results Oct. 27, thanks to a big investment in digital strategies and the ability to pass along higher costs to customers. In fact, digital strategies may not be top of mind for investors when they think of McDonald's, but the future is digital and self-serve.
Deglobalization Bonanza for Semiconductors
Deglobalization and energy transition will be a boon for the chip sector. In fact, investors should buy semiconductor equipment stocks into the next pullback, thanks to the multiplying effect of deglobalization and energy transition. For the better part of the past three decades, Western companies have been busy offshoring production capacity to China and other countries in Southeast Asia. But the world is changing fast, and semiconductors are integral to future infrastructure.
Moderna's High Efficacy Means High Share Prices
Medical researchers are using what they know about our immune system and computers to make startling advances. There has never been a better time for investors, and they should buy Moderna shares into any future weakness. Moderna is famous for its groundbreaking work with messenger RNA technology. This is the same tech that was used to quickly develop a vaccine for the COVID-19 virus. Now the company is pushing beyond respiratory illnesses and working to develop drug treatments that can attack solid tumors, like cancer. This is a big deal and a huge trend moving forward.
That's it for today. I'll be back with more exciting content and growing trends for you to take advantage of in the new year.
Until then, wishing you a happy and prosperous 2023!
All the best,
Jon D. Markman
